182 related articles for article (PubMed ID: 32823003)
1. Endeavors towards transformation of M. tuberculosis thymidylate kinase (MtbTMPK) inhibitors into potential antimycobacterial agents.
Jian Y; Merceron R; De Munck S; Forbes HE; Hulpia F; Risseeuw MDP; Van Hecke K; Savvides SN; Munier-Lehmann H; Boshoff HIM; Van Calenbergh S
Eur J Med Chem; 2020 Nov; 206():112659. PubMed ID: 32823003
[TBL] [Abstract][Full Text] [Related]
2. 1-(1-Arylethylpiperidin-4-yl)thymine Analogs as Antimycobacterial TMPK Inhibitors.
Jian Y; Hulpia F; D P Risseeuw M; Forbes HE; Caljon G; Munier-Lehmann H; I M Boshoff H; Van Calenbergh S
Molecules; 2020 Jun; 25(12):. PubMed ID: 32560578
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure activity relationships of cyanopyridone based anti-tuberculosis agents.
Jian Y; Hulpia F; Risseeuw MDP; Forbes HE; Munier-Lehmann H; Caljon G; Boshoff HIM; Van Calenbergh S
Eur J Med Chem; 2020 Sep; 201():112450. PubMed ID: 32623208
[TBL] [Abstract][Full Text] [Related]
4. 1-(Piperidin-3-yl)thymine amides as inhibitors of
Jian Y; Risseeuw MDP; Froeyen M; Song L; Cappoen D; Cos P; Munier-Lehmann H; van Calenbergh S
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1730-1739. PubMed ID: 31822127
[TBL] [Abstract][Full Text] [Related]
5. Elaboration of a proprietary thymidylate kinase inhibitor motif towards anti-tuberculosis agents.
Song L; Risseeuw MDP; Froeyen M; Karalic I; Goeman J; Cappoen D; Van der Eycken J; Cos P; Munier-Lehmann H; Van Calenbergh S
Bioorg Med Chem; 2016 Nov; 24(21):5172-5182. PubMed ID: 27614917
[TBL] [Abstract][Full Text] [Related]
6. Drug design and identification of potent leads against mycobacterium tuberculosis thymidine monophosphate kinase.
Van Calenbergh S; Pochet S; Munier-Lehmann H
Curr Top Med Chem; 2012; 12(7):694-705. PubMed ID: 22283813
[TBL] [Abstract][Full Text] [Related]
7. Structure-aided optimization of non-nucleoside M. tuberculosis thymidylate kinase inhibitors.
Song L; Merceron R; Hulpia F; Lucía A; Gracia B; Jian Y; Risseeuw MDP; Verstraelen T; Cos P; Aínsa JA; Boshoff HI; Munier-Lehmann H; Savvides SN; Van Calenbergh S
Eur J Med Chem; 2021 Dec; 225():113784. PubMed ID: 34450493
[TBL] [Abstract][Full Text] [Related]
8. A new family of inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase.
Gasse C; Huteau V; Douguet D; Munier-Lehmann H; Pochet S
Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1057-61. PubMed ID: 18058536
[No Abstract] [Full Text] [Related]
9. In silico Design and Synthesis of Tetrahydropyrimidinones and Tetrahydropyrimidinethiones as Potential Thymidylate Kinase Inhibitors Exerting Anti-TB Activity Against
Venugopala KN; Tratrat C; Pillay M; Chandrashekharappa S; Al-Attraqchi OHA; Aldhubiab BE; Attimarad M; Alwassil OI; Nair AB; Sreeharsha N; Venugopala R; Morsy MA; Haroun M; Kumalo HM; Odhav B; Mlisana K
Drug Des Devel Ther; 2020; 14():1027-1039. PubMed ID: 32214795
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of thymidine-5'-O-monophosphate analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.
Vanheusden V; Munier-Lehmann H; Pochet S; Herdewijn P; Van Calenbergh S
Bioorg Med Chem Lett; 2002 Oct; 12(19):2695-8. PubMed ID: 12217356
[TBL] [Abstract][Full Text] [Related]
11. Structure-aided design of inhibitors of Mycobacterium tuberculosis thymidylate kinase.
Van Calenbergh S
Verh K Acad Geneeskd Belg; 2006; 68(4):223-48. PubMed ID: 17214439
[TBL] [Abstract][Full Text] [Related]
12. Structure Guided Lead Generation toward Nonchiral M. tuberculosis Thymidylate Kinase Inhibitors.
Song L; Merceron R; Gracia B; Quintana AL; Risseeuw MDP; Hulpia F; Cos P; Aínsa JA; Munier-Lehmann H; Savvides SN; Van Calenbergh S
J Med Chem; 2018 Apr; 61(7):2753-2775. PubMed ID: 29510037
[TBL] [Abstract][Full Text] [Related]
13. Exploring acyclic nucleoside analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.
Familiar O; Munier-Lehmann H; Negri A; Gago F; Douguet D; Rigouts L; Hernández AI; Camarasa MJ; Pérez-Pérez MJ
ChemMedChem; 2008 Jul; 3(7):1083-93. PubMed ID: 18418833
[TBL] [Abstract][Full Text] [Related]
14. 5-Arylaminouracil Derivatives: New Inhibitors of Mycobacterium tuberculosis.
Matyugina E; Novikov M; Babkov D; Ozerov A; Chernousova L; Andreevskaya S; Smirnova T; Karpenko I; Chizhov A; Murthu P; Lutz S; Kochetkov S; Seley-Radtke KL; Khandazhinskaya AL
Chem Biol Drug Des; 2015 Dec; 86(6):1387-96. PubMed ID: 26061192
[TBL] [Abstract][Full Text] [Related]
15. Thymidine and thymidine-5'-O-monophosphate analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.
Vanheusden V; Van Rompaey P; Munier-Lehmann H; Pochet S; Herdewijn P; Van Calenbergh S
Bioorg Med Chem Lett; 2003 Sep; 13(18):3045-8. PubMed ID: 12941330
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of 5'-modified thymidines and 5-hydroxymethyl-2'-deoxyuridines as Mycobacterium tuberculosis thymidylate kinase inhibitors.
Toti KS; Verbeke F; Risseeuw MD; Frecer V; Munier-Lehmann H; Van Calenbergh S
Bioorg Med Chem; 2013 Jan; 21(1):257-68. PubMed ID: 23199481
[TBL] [Abstract][Full Text] [Related]
17. Rational design and 3D-pharmacophore mapping of 5'-thiourea-substituted alpha-thymidine analogues as mycobacterial TMPK inhibitors.
Andrade CH; Pasqualoto KF; Ferreira EI; Hopfinger AJ
J Chem Inf Model; 2009 Apr; 49(4):1070-8. PubMed ID: 19296716
[TBL] [Abstract][Full Text] [Related]
18. Database searching for thymidine and thymidylate kinase inhibitors using three-dimensional structure-based methods.
Manallack DT; Pitt WR; Herdewijn P; Balzarini J; De Clercq E; Sanderson MR; Sohi M; Wien F; Munier-Lehmann H; Haouz A; Delarue M
J Enzyme Inhib Med Chem; 2002 Jun; 17(3):167-74. PubMed ID: 12443042
[TBL] [Abstract][Full Text] [Related]
19. Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: synthesis and in vitro anti-mycobacterial activity.
Gasse C; Douguet D; Huteau V; Marchal G; Munier-Lehmann H; Pochet S
Bioorg Med Chem; 2008 Jun; 16(11):6075-85. PubMed ID: 18467107
[TBL] [Abstract][Full Text] [Related]
20. Computer-assisted combinatorial design of bicyclic thymidine analogs as inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase.
Frecer V; Seneci P; Miertus S
J Comput Aided Mol Des; 2011 Jan; 25(1):31-49. PubMed ID: 21082329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
